These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33813948)

  • 1. Choice of Intensive Lifestyle Change and/or Metformin after Shared Decision Making for Diabetes Prevention: Results from the Prediabetes Informed Decisions and Education (PRIDE) Study.
    Moin T; Martin JM; Mangione CM; Grotts J; Turk N; Norris KC; Tseng CH; Jeffers KS; Castellon-Lopez Y; Frosch DL; Duru OK
    Med Decis Making; 2021 Jul; 41(5):607-613. PubMed ID: 33813948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial.
    Moin T; Duru OK; Turk N; Chon JS; Frosch DL; Martin JM; Jeffers KS; Castellon-Lopez Y; Tseng CH; Norris K; Mangione CM
    J Gen Intern Med; 2019 Nov; 34(11):2652-2659. PubMed ID: 31471729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of Shared Decision-making for Diabetes Prevention: 24- and 36-Month Results From the Prediabetes Informed Decision and Education (PRIDE) Trial.
    Duru OK; Mangione CM; Turk N; Chon J; Fu J; Cheng G; Cheng F; Moss A; Frosch D; Jeffers KS; Castellon-Lopez Y; Tseng CH; Maranon R; Norris KC; Moin T
    Diabetes Care; 2023 Dec; 46(12):2218-2222. PubMed ID: 37770039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of a shared decision making intervention for diabetes prevention for women with a history of gestational diabetes mellitus: The Gestational diabetes Risk Attenuation for New Diabetes (GRAND study).
    Madievsky R; Vu A; Cheng F; Chon J; Turk N; Krueger A; Krong J; Maranon R; Liu S; Han CS; Norris KC; Mangione C; Page J; Thomas S; Duru OK; Moin T
    Contemp Clin Trials; 2023 Jan; 124():107007. PubMed ID: 36384219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of metformin for type 2 diabetes prevention: Observational multicenter study from Saudi Arabia.
    Alfayez OM; Alsallum AA; Aljabri AF; Almutairi FS; Al-Azzeh O; Almalki OS; Al Yami MS; Almohammed OA
    Front Public Health; 2022; 10():989072. PubMed ID: 36159298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study.
    Moin T; Li J; Duru OK; Ettner S; Turk N; Keckhafer A; Ho S; Mangione CM
    Ann Intern Med; 2015 Apr; 162(8):542-8. PubMed ID: 25894024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.
    Goldberg RB; Temprosa M; Mele L; Orchard T; Mather K; Bray G; Horton E; Kitabchi A; Krakoff J; Marcovina S; Perreault L; White N;
    Metabolism; 2016 May; 65(5):764-775. PubMed ID: 27085783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.
    Perreault L; Pan Q; Mather KJ; Watson KE; Hamman RF; Kahn SE;
    Lancet; 2012 Jun; 379(9833):2243-51. PubMed ID: 22683134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.
    Goldberg RB; Aroda VR; Bluemke DA; Barrett-Connor E; Budoff M; Crandall JP; Dabelea D; Horton ES; Mather KJ; Orchard TJ; Schade D; Watson K; Temprosa M;
    Circulation; 2017 Jul; 136(1):52-64. PubMed ID: 28476766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Perceptions About Prediabetes and Preferences for Diabetes Prevention.
    O'Brien MJ; Moran MR; Tang JW; Vargas MC; Talen M; Zimmermann LJ; Ackermann RT; Kandula NR
    Diabetes Educ; 2016 Dec; 42(6):667-677. PubMed ID: 27621093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model-A multiregional case study.
    Al-Omar HA; Czech M; Quang Nam T; Gottwald-Hostalek U; Vesic N; Whitehouse J; Dawson M
    J Diabetes; 2024 May; 16(5):e13553. PubMed ID: 38664882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapeutic options for prediabetes.
    Rendell M
    Expert Opin Pharmacother; 2021 Jan; 22(1):45-54. PubMed ID: 32892663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin in Prevention of Type 2 Diabetes.
    Snehalatha C; Priscilla S; Nanditha A; Arun R; Satheesh K; Ramachandran A
    J Assoc Physicians India; 2018 Mar; 66(3):60-3. PubMed ID: 30341871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PREVENT-DM Comparative Effectiveness Trial of Lifestyle Intervention and Metformin.
    O'Brien MJ; Perez A; Scanlan AB; Alos VA; Whitaker RC; Foster GD; Ackermann RT; Ciolino JD; Homko C
    Am J Prev Med; 2017 Jun; 52(6):788-797. PubMed ID: 28237635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Beliefs Associated With Metformin Use Among Insured Adults With Prediabetes.
    McEwen LN; Hurst TE; Joiner KL; Herman WH
    Diabetes Care; 2022 Oct; 45(10):2282-2288. PubMed ID: 35926099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.
    Goldberg RB; Mather K
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2077-90. PubMed ID: 22895669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
    Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
    Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Metformin Use for Type 2 Diabetes Prevention.
    Moin T; Schmittdiel JA; Flory JH; Yeh J; Karter AJ; Kruge LE; Schillinger D; Mangione CM; Herman WH; Walker EA
    Am J Prev Med; 2018 Oct; 55(4):565-574. PubMed ID: 30126667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.
    Guardado-Mendoza R; Salazar-López SS; Álvarez-Canales M; Farfán-Vázquez D; Martínez-López YE; Jiménez-Ceja LM; Suárez-Pérez EL; Angulo-Romero F; Evia-Viscarra ML; Montes de Oca-Loyola ML; Durán-Pérez EG; Folli F; Aguilar-García A
    Metabolism; 2020 Mar; 104():154054. PubMed ID: 31887309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
    ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
    Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.